Literature DB >> 35261852

Posterior reversible encephalopathy syndrome due to arterial hypertension may mark the onset of the symptomatic phase in Huntington's disease.

Maurizio Giorelli1.   

Abstract

Autonomic dysregulation of cardiovascular functions marks early Huntingtons disease (HD). Blood-brain barrier (BBB) is dysfunctional in HD. A 37-year-old female carrying 41 CAG triplets in the huntingtin gene acutely presented with a multifaceted syndrome attributable to posterior reversible encephalopathy syndrome (PRES). Syndrome was associated with arterial hypertension (AHT). The syndrome fully recovered both by imaging and clinical signs after normalization of arterial pressure during hospitalization. Immediately after hospital discharge, the patient developed a complex psychiatric syndrome and choreic movements that represented conversion to the symptomatic phase of HD. A one-year later follow up clearly showed the patient had developed the symptomatic stage of HD by presenting both psychiatric symptoms and choreic movements. Onset of AHT may represent an early premonitory signal of HD becoming manifested. Induction of PRES might be associated with BBB impairment in HD. 2022, International Research and Cooperation Association for Bio & Socio - Sciences Advancement.

Entities:  

Keywords:  Huntington's disease; arterial hypertension; autonomic dysfunction; blood-brain barrier; posterior reversible encephalopathy syndrome

Year:  2022        PMID: 35261852      PMCID: PMC8898392          DOI: 10.5582/irdr.2021.01148

Source DB:  PubMed          Journal:  Intractable Rare Dis Res        ISSN: 2186-3644


  9 in total

1.  Early sympathetic hyperactivity in Huntington's disease.

Authors:  J Kobal; B Meglic; A Mesec; B Peterlin
Journal:  Eur J Neurol       Date:  2004-12       Impact factor: 6.089

Review 2.  Understanding posterior reversible encephalopathy syndrome.

Authors:  Kenneth Fittro; Roderick Dizon
Journal:  JAAPA       Date:  2018-07

3.  Cerebrovascular and blood-brain barrier impairments in Huntington's disease: Potential implications for its pathophysiology.

Authors:  Janelle Drouin-Ouellet; Stephen J Sawiak; Giulia Cisbani; Marie Lagacé; Wei-Li Kuan; Martine Saint-Pierre; Richard J Dury; Wael Alata; Isabelle St-Amour; Sarah L Mason; Frédéric Calon; Steve Lacroix; Penny A Gowland; Susan T Francis; Roger A Barker; Francesca Cicchetti
Journal:  Ann Neurol       Date:  2015-04-09       Impact factor: 10.422

4.  Circadian rhythm and autonomic dysfunction in presymptomatic and early Huntington's disease.

Authors:  Elena Bellosta Diago; Jesús Pérez Pérez; Sonia Santos Lasaosa; Alejandro Viloria Alebesque; Saül Martínez Horta; Jaime Kulisevsky; Javier López Del Val
Journal:  Parkinsonism Relat Disord       Date:  2017-09-15       Impact factor: 4.891

Review 5.  Blood-brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders.

Authors:  Melanie D Sweeney; Abhay P Sagare; Berislav V Zlokovic
Journal:  Nat Rev Neurol       Date:  2018-01-29       Impact factor: 42.937

6.  Venezuelan kindreds reveal that genetic and environmental factors modulate Huntington's disease age of onset.

Authors:  Nancy S Wexler; Judith Lorimer; Julie Porter; Fidela Gomez; Carol Moskowitz; Edith Shackell; Karen Marder; Graciela Penchaszadeh; Simone A Roberts; Javier Gayán; Denise Brocklebank; Stacey S Cherny; Lon R Cardon; Jacqueline Gray; Stephen R Dlouhy; Sandra Wiktorski; Marion E Hodes; P Michael Conneally; Jack B Penney; James Gusella; Jang-Ho Cha; Michael Irizarry; Diana Rosas; Steven Hersch; Zane Hollingsworth; Marcy MacDonald; Anne B Young; J Michael Andresen; David E Housman; Margot Mieja De Young; Ernesto Bonilla; Theresa Stillings; Americo Negrette; S Robert Snodgrass; Maria Dolores Martinez-Jaurrieta; Maria A Ramos-Arroyo; Jacqueline Bickham; Juan Sanchez Ramos; Frederick Marshall; Ira Shoulson; Gustavo J Rey; Andrew Feigin; Norman Arnheim; Amarilis Acevedo-Cruz; Leticia Acosta; Jose Alvir; Kenneth Fischbeck; Leslie M Thompson; Angela Young; Leon Dure; Christopher J O'Brien; Jane Paulsen; Adam Brickman; Denise Krch; Shelley Peery; Penelope Hogarth; Donald S Higgins; Bernhard Landwehrmeyer
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-01       Impact factor: 11.205

7.  Identification of Genetic Factors that Modify Clinical Onset of Huntington's Disease.

Authors: 
Journal:  Cell       Date:  2015-07-30       Impact factor: 41.582

8.  Autonomic dysfunction in presymptomatic and early symptomatic Huntington's disease.

Authors:  J Kobal; Z Melik; K Cankar; F F Bajrovic; B Meglic; B Peterlin; M Zaletel
Journal:  Acta Neurol Scand       Date:  2009-12-28       Impact factor: 3.209

9.  Does arterial hypertension influence the onset of Huntington's disease?

Authors:  Leire Valcárcel-Ocete; Asier Fullaondo; Gorka Alkorta-Aranburu; María García-Barcina; Raymund A C Roos; Lena E Hjermind; Carsten Saft; Marina Frontali; Ralf Reilmann; Hugh Rickards; Ana M Zubiaga; Ana Aguirre
Journal:  PLoS One       Date:  2018-05-23       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.